Fineotex Chemical Ltd logo

Fineotex Chemical Ltd

FCL NSE

Key Fundamentals

MicrocapSpecialty ChemicalsChemicals
Market Cap
₹4,993 Cr
Volatility
Moderate
P/E Ratio
40.93
EBITDA
₹135 Cr
Return on Equity
14.78%
Debt to Equity
0.01
Book Value
₹7.58
EPS
₹11.09
52W High
₹47.18
52W Low
₹19.1

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Fineotex Chemical Ltd insights

59 extracted metrics + investor summaries across FY10–FY26.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Strengths

2
  • Company is almost debt free.
  • Company is expected to give good quarter

Weaknesses

1
  • Debtor days have increased from 102 to 137 days.

Growth Rate

Revenue Growth
38.49% ↗
Net Income Growth
15.83% ↗
Cash Flow Change
-28.56% ↘
ROE
-44.60% ↘
ROCE
-45.03% ↘
EBITDA Margin (Avg.)
-38.42% ↘

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 18d ago
AI opinion · based on fundamentals
Risk medium

Fineotex Chemical Ltd is a nearly debt-free specialty chemicals company with a market cap of ₹4,489 Cr trading at a P/E of 29.8x. The company delivered strong TTM sales growth of 91% (driven by Q4 FY26 revenue up 162% YoY to ₹313.7 Cr), though FY25 consolidated PAT declined 9.8% YoY to ₹109 Cr and ROE has compressed from a 5-year average of 21% to 13% in the last year.

Bull Case 8
  • Near debt-free balance sheet provides financial flexibility and low interest burden (interest cost just ₹0.53 Cr in FY25 vs operating profit of ₹81+ Cr)
  • Q4 FY26 consolidated revenue surged 162% YoY to ₹313.7 Cr, signaling strong demand recovery and possible inflection in growth trajectory
  • TTM compounded sales growth of 91% is significantly ahead of the 10-year CAGR of 22%, indicating accelerating top-line momentum
  • 10-year compounded profit CAGR of 20% and 10-year stock CAGR of 31% demonstrate long-term consistent value creation
  • 5-year average ROE of 21% reflects efficient capital deployment over a meaningful time period
  • Dividend yield of 2.12% is attractive for a growth-oriented specialty chemicals mid-cap, providing some downside support
  • P/B ratio of 4.99x is supported by consistently high return ratios (5-year ROE of 21%), suggesting the premium is backed by earnings quality
  • Company is expected to deliver a good upcoming quarter per market consensus, building on the Q4 FY26 momentum
Bear Case 7
  • Debtor days have increased sharply from 102 to 137 days, indicating deteriorating working capital efficiency and potential collection risk
  • FY25 consolidated PAT declined to ₹109.2 Cr from ₹121 Cr in FY24, a fall of approximately 9.8% YoY despite revenue being largely flat
  • Last year ROE compressed to 13% from a 5-year average of 21%, representing a 38% decline in return on equity
  • 3-year compounded profit CAGR of only 7% lags the 3-year sales CAGR of 14%, suggesting margin pressure and inability to convert revenue growth into proportional profit growth
  • P/E of 29.8x is elevated relative to the recent profit growth of 7% (3-year CAGR), implying a PEG ratio well above 1x
  • FY25 consolidated PBT fell to ₹141.2 Cr from ₹157.6 Cr in FY24, showing pre-tax margin compression from roughly 27% to 25%
  • TTM profit growth of 17% materially trails TTM sales growth of 91%, raising questions about operating leverage and cost discipline at scale

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 15d ago
Positives 1
  • Q1FY27 PAT surges 93% Jul 23

    Consolidated PAT jumped 92.61% to ₹4,821 Lakhs in Q1FY27, backed by 164.48% revenue growth and 130.84% volume growth. Statutory auditors issued an unqualified review report, indicating clean financials.

Neutral 1
  • Q1 FY27 earnings call scheduled Jul 20

    Fineotex Chemical will host an analyst conference call on July 24, 2026 at 5:00 PM IST to discuss Q1 FY27 results.

TL;DR: Fineotex Chemical delivered an exceptionally strong Q1FY27 with PAT nearly doubling and volumes more than doubling, signalling robust demand and operational execution. No headwinds are visible in recent coverage. The trend is clearly improving, and the upcoming earnings call on Jul 24 may provide further clarity on sustainability of this growth trajectory.

Quarterly Results

  Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
132
145
138
153
142
146
126
120
137
138
184
314
377
Expenses
101
107
98
115
107
109
92
99
112
107
149
270
317
Operating Profit
32
38
40
38
35
36
34
21
25
31
35
44
59
OPM %
24%
26%
29%
25%
25%
25%
27%
18%
18%
23%
19%
14%
16%
Other Income
4
4
5
4
5
7
5
8
9
8
7
9
10
Interest
0
0
0
1
0
0
0
0
0
0
0
1
0
Depreciation
1
1
1
2
2
2
3
2
3
3
3
4
4
PBT
34
40
44
40
38
41
36
26
31
35
38
48
65
Tax %
22%
22%
24%
24%
22%
21%
24%
24%
21%
26%
21%
9%
26%
Net Profit
26
31
33
30
29
32
28
20
25
26
30
44
48
EPS in Rs
0.23
0.28
0.29
0.27
0.26
0.28
0.24
0.17
0.22
0.23
0.23
0.27
0.33
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
102
110
127
141
182
196
219
368
517
569
533
772
1,012
Expenses
85
82
98
111
148
162
178
297
404
421
406
637
843
Operating Profit
16
28
29
30
34
35
41
71
113
148
127
135
169
OPM %
16%
26%
23%
21%
19%
18%
19%
19%
22%
26%
24%
17%
17%
Other Income
5
2
10
5
1
-11
17
6
7
17
24
33
34
Interest
0
0
0
1
1
1
1
1
1
1
1
1
1
Depreciation
0
1
1
1
1
1
1
3
4
6
9
13
15
PBT
20
29
38
34
34
22
56
73
115
158
141
153
186
Tax %
28%
31%
24%
29%
28%
35%
20%
22%
22%
23%
23%
18%
—
Net Profit
15
20
29
24
24
14
45
57
90
121
109
125
148
EPS in Rs
0.11
0.16
0.23
0.2
0.2
0.12
0.38
0.5
0.8
1.08
0.94
0.93
1.06
Div. Payout %
9%
13%
4%
10%
5%
4%
8%
8%
10%
15%
8%
3%
—
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
22
22
22
22
22
22
22
22
22
22
23
116
Reserves
54
69
90
113
137
147
187
240
327
425
708
766
Borrowings
2
3
1
5
2
3
3
2
7
5
0
8
Other Liabilities
23
20
26
21
34
35
54
75
67
96
83
269
Total Liabilities
101
114
140
161
195
208
267
339
423
548
815
1,159
Fixed Assets
18
19
27
29
36
41
59
84
99
141
179
278
CWIP
0
0
0
0
0
1
5
0
0
0
21
2
Investments
29
39
47
55
48
52
32
17
89
147
330
317
Other Assets
54
56
66
77
110
114
171
238
234
260
284
562
Total Assets
101
114
140
161
195
208
267
339
423
548
815
1,159
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
14
14
19
6
12
28
9
13
107
97
69
-24
Investing
-14
-13
-14
-6
5
-19
-7
1
-99
-47
-273
105
Financing
-3
-1
-6
-4
-3
-4
-4
-6
-6
-24
176
-63
Net Cash Flow
-3
-1
-1
-3
14
6
-2
8
1
26
-27
19
Free Cash Flow
8
12
14
4
4
22
-15
-9
88
49
1
-49
CFO/OP
109
84
104
52
63
104
46
43
119
92
77
0
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
80
84
84
72
98
100
138
110
72
89
79
137
Inventory Days
56
66
70
97
84
66
79
98
53
55
75
109
Days Payable
75
75
82
50
70
73
101
96
53
79
66
114
Cash Conversion Cycle
60
75
72
119
112
93
116
111
72
64
88
133
Working Capital Days
58
73
73
114
118
107
136
125
71
76
104
153
ROCE %
21%
31%
35%
26%
22%
20%
28%
30%
36%
39%
24%
18%

Shareholding Pattern

As of Jun 2026
Promoters 62.30%
Public 29.47%
Others 3.71%
FIIs 3.16%
DIIs 1.36%
Total 100.00%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024May 2024Jun 2024Jul 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Nov 2025Dec 2025Jan 2026Mar 2026Jun 2026
Promoters
64.74%
64.82%
64.82%
64.82%
64.82%
64.94%
64.97%
65.00%
65.04%
65.03%
65.03%
65.03%
65.03%
64.46%
64.46%
62.88%
62.88%
62.86%
62.88%
62.88%
62.88%
62.57%
62.57%
62.30%
62.30%
62.30%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.81%
1.45%
0.97%
0.93%
3.14%
3.28%
3.36%
2.84%
2.51%
2.34%
2.52%
2.52%
2.94%
2.92%
3.16%
DIIs
6.15%
6.15%
6.15%
6.15%
6.15%
5.35%
4.01%
3.65%
3.65%
3.65%
3.68%
3.69%
3.70%
3.68%
3.68%
3.59%
3.63%
3.61%
3.71%
3.17%
1.63%
1.28%
1.28%
1.27%
1.27%
1.36%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
22.58%
22.48%
22.76%
23.13%
24.41%
26.23%
27.54%
28.19%
27.97%
27.94%
28.07%
27.81%
27.03%
27.86%
27.80%
27.12%
27.09%
26.94%
27.04%
27.97%
29.66%
30.03%
29.98%
29.85%
29.75%
29.47%
Others
6.53%
6.55%
6.27%
5.90%
4.62%
3.48%
3.49%
3.17%
3.34%
3.38%
3.22%
2.65%
2.80%
3.03%
3.13%
3.28%
3.12%
3.23%
3.53%
3.47%
3.47%
3.60%
3.65%
3.63%
3.76%
3.71%
No. of Shareholders
38,127
47,827
64,077
63,047
64,851
72,146
1,05,710
1,10,855
1,10,312
1,13,469
1,16,801
1,16,067
1,22,095
1,25,460
1,26,673
1,26,676
1,28,268
1,29,068
1,33,899
1,36,842
1,46,522
1,53,373
1,64,466
1,64,467
1,62,276
1,80,711

Documents

1
Concall - Mar 2017 Mar 2017
2
Concall - May 2017 May 2017
3
Concall - Sep 2017 Sep 2017
4
Concall - Sep 2017 Sep 2017
5
Concall - Dec 2017 Dec 2017

Frequently Asked Questions about Fineotex Chemical Ltd

What does Fineotex Chemical Ltd do?
Incorporated in 1979, Fineotex Chemicals Ltd is engaged in the business of manufacturing auxiliaries and specialty chemicals for textiles, construction, water treatment, fertilizer, leather, and paint industries[1]
Where is Fineotex Chemical Ltd (FCL) listed?
Fineotex Chemical Ltd is listed on the Indian stock exchanges. It is listed on NSE: FCL and BSE: 533333. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Fineotex Chemical Ltd belong to?
Fineotex Chemical Ltd operates in the Chemicals sector within the Specialty Chemicals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Fineotex Chemical Ltd?
Fineotex Chemical Ltd has a market capitalisation of approximately ₹4993.38 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Fineotex Chemical Ltd?
The Price-to-Earnings (PE) ratio of Fineotex Chemical Ltd is 40.93. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Fineotex Chemical Ltd?
Over the past 52 weeks, Fineotex Chemical Ltd has traded between a low of ₹19.1 and a high of ₹47.18. This range helps investors understand the stock's price volatility and recent trading levels.
Does Fineotex Chemical Ltd pay dividends?
Yes, Fineotex Chemical Ltd has a dividend yield of 1.84%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Fineotex Chemical Ltd?
Fineotex Chemical Ltd has a Return on Equity (ROE) of 14.78%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Fineotex Chemical Ltd on Tapetide?
On Tapetide, you can view Fineotex Chemical Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Incorporated in 1979, Fineotex Chemicals Ltd is engaged in the business of manufacturing auxiliaries and specialty chemicals for textiles, construction, water treatment, fertilizer, leather, and paint industries[1]

Website fineotex.com
CEO Mr. Surendrakumar Deviprasad Tibrewala B.Com, LLB
Employees 210
Listed 2015-01-15
Face Value ₹ 1
Issued Size 1,14,57,50,900

Explore More

More in Chemicals → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List